Abstract
Abnormal activation of the sympathetic nervous system can induce cardiac hypertrophy and ultimately heart failure. To shed lights into the downstream effectors of the earlier stages of pathological hypertrophy, mice were treated for seven days with isoproterenol and cardiomyocytes isolated from hypertrophic hearts were studied by proteomics. Potential earlier markers for heart failure and therapeutic targets are reported. This is reported by Ricardo Cambraia Parreira, Diana Paola Gómez-Mendoza, Itamar Couto Guedes de Jesus, Rafael Pereira Lemos, Anderson Kennedy Santos, Cristiana Perdigão Rezende, Henrique César Pereira Figueiredo, Mauro Cunha Xavier Pinto, Frank Kjeldsen, Silvia Guatimosim, Rodrigo Ribeiro Resende, Thiago Verano-Braga in article 2000017.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
